These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14182676)

  • 21. THE STABILIZING EFFECT OF L-CYSTINE ON THE THERMAL INACTIVATION OF POLIOVIRUS. I. DIFFERENTIATION OF THE STRAINS OF POLIOVIRUS BY HEATING WITH L-CYSTINE.
    IKEGAMI N; YOSHIKAWA E; TAGAYA I
    Jpn J Med Sci Biol; 1963 Dec; 16():325-42. PubMed ID: 14130752
    [No Abstract]   [Full Text] [Related]  

  • 22. NEUTRALIZING ANTIBODIES IN FAECAL EXTRACTS DURING POLIOMYELITIS LIVE VACCINE IMMUNIZATION.
    MASSON AM; ROGALA E; ROLLAND D
    Can J Public Health; 1965 Jul; 56():276-80. PubMed ID: 14343213
    [No Abstract]   [Full Text] [Related]  

  • 23. [POLIOMYELITIS IN THE CHILD. REFERENCES TO VIROLOGICAL FINDINGS].
    GONZALEZ M; SCROGGIE S; DIAZ R
    Rev Chil Pediatr; 1964 Jan; 35():24-8. PubMed ID: 14163294
    [No Abstract]   [Full Text] [Related]  

  • 24. ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.
    DEIBEL R; MACDONALD D
    N Y State J Med; 1964 Aug; 64():2058-65. PubMed ID: 14180893
    [No Abstract]   [Full Text] [Related]  

  • 25. THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN.
    PAGANO JS; BOETTIGER M; BONNEVIER JO; GARD S
    Am J Hyg; 1964 Jan; 79():74-85. PubMed ID: 14114357
    [No Abstract]   [Full Text] [Related]  

  • 26. CHROMATOGRAPHY OF POLIOVIRUS ON CALCIUM PHOSPHATE AND ITS APPLICATION TO THE IDENTIFICATION OF VACCINE PROGENY STRAINS.
    OZAKI Y; DIWAN AR; TAKIZAWA M; MELNICK JL
    J Bacteriol; 1965 Mar; 89(3):603-10. PubMed ID: 14273634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolation of poliovirus in various tissue cultures].
    Wigand R; Lang F; Adam W; Bauer H
    Z Hyg Infektionskr; 1964; 150(2):136-41. PubMed ID: 4284115
    [No Abstract]   [Full Text] [Related]  

  • 28. REVERSIBLE INHIBITION OF POLIOVIRUS RIBONUCLEIC ACID.
    ENGLER R; TOLBERT O
    Arch Gesamte Virusforsch; 1963 Aug; 13():470-81. PubMed ID: 14078838
    [No Abstract]   [Full Text] [Related]  

  • 29. THE RESPONSE OF PREMATURE INFANTS TO INFECTION WITH TYPE 3 ATTENUATED POLIOVIRUS.
    PAGANO JS; PLOTKIN SA; CORNELY D
    J Pediatr; 1964 Aug; 65():165-75. PubMed ID: 14198406
    [No Abstract]   [Full Text] [Related]  

  • 30. [RESEARCH "IN VITRO" ON THE ANTIPOLIOMYELITIC ACTIVITY OF GUANIDINE AND ON ITS CAPACITY TO INDURE A GUANIDINE-DEPENDENCE OF THE VIRUS].
    BROTZU G; FERRARI W; LODDO B; SPANEDDA A
    G Ital Chemioter; 1963; 10():1-23. PubMed ID: 14079388
    [No Abstract]   [Full Text] [Related]  

  • 31. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 32. Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.
    Janda Z; Adam E; Vonka V
    Arch Gesamte Virusforsch; 1967; 20(1):87-98. PubMed ID: 4299774
    [No Abstract]   [Full Text] [Related]  

  • 33. Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.
    Simon J; Vonka V; Janda Z
    Arch Gesamte Virusforsch; 1965; 15(5):681-9. PubMed ID: 4285635
    [No Abstract]   [Full Text] [Related]  

  • 34. STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).
    VONKA V; TARABCAK M; JANDA Z
    Arch Gesamte Virusforsch; 1964; 14():169-76. PubMed ID: 14141577
    [No Abstract]   [Full Text] [Related]  

  • 35. STUDIES ON THE SALK AND LIVE ATTENUATED POLIOVIRUS VACCINE.
    NISHIZAWA Y; KODAMA T; MAJIMA E; ARAKI M; CHIN S
    Biken J; 1963 Jul; 6():97-110. PubMed ID: 14147708
    [No Abstract]   [Full Text] [Related]  

  • 36. [METHODS AND RESULTS OF PREPARATION OF LIVE POLIOMYELITIS VACCINE, NOT CONTAINING MIXTURES OF VACUOLIZING VIRUS (OB40-SV40)].
    CHUMAKOV MP; DZAGUROV SG; LASHKEVICH VA; GRACHEV VP; MIRONOVA LL; RALF NM; ELBERT LB
    Vopr Virusol; 1963; 29():445-9. PubMed ID: 14071282
    [No Abstract]   [Full Text] [Related]  

  • 37. A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. II. POLIOVIRUS ANTIBODY LEVELS.
    NIEDERMAN JC; OPTON EM
    Am J Hyg; 1964 Nov; 80():293-303. PubMed ID: 14225919
    [No Abstract]   [Full Text] [Related]  

  • 38. POLIOVIRUS VARIATION AND THE PRODUCTION OF ATTENUATED STRAINS FOR VACCINES.
    HOSKINS JM
    Curr Med Drugs; 1963 Apr; 3(8):15-21. PubMed ID: 14087455
    [No Abstract]   [Full Text] [Related]  

  • 39. COMPARATIVE SEROLOGICAL STUDIES ON THE EFFECTIVENESS OF MONOVALENT LIVE POLIOVIRUS VACCINES GIVEN ALTERNATIVELY IN THE ORDER 2-3-1 AND 1-3-2.
    FORNOSI F; TALOS I
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():263-9. PubMed ID: 14267556
    [No Abstract]   [Full Text] [Related]  

  • 40. Aluminum-marker of wild type 1 poliovirus strains.
    Nakao C; Tagaya I; Komatsu T; Kodama H
    Jpn J Microbiol; 1970 Sep; 14(5):405-12. PubMed ID: 4319729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.